Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

McMaster University

$300,236.00

A randomized trial of a shorter radiation fraction schedule for the treatment of localised prostate cancer

EF 2009-10

Résumé
Prostate cancer is the most common cancer affecting Canadian men, and radiotherapy given from the outside (external beam) is frequently chosen by patients as an alternative to surgery to eradicate the tumour and cure the disease. Recent improvements in radiation treatment allow more radiation dose to be safely given than before, but this has extended the duration of a treatment course from a traditional 6-7 weeks to up to 8-9 weeks. Extending radiation treatment courses has improved cancer control, but is more inconvenient to patients and has placed a substantial economic burden on the health care system. Canadians often live remotely from radiation treatment centres, and prostate cancer patients have also been burdened with additional financial, emotional and social costs from the added weeks of treatment. This randomized trial is being conducted in centres across Canada and in Australia to determine whether an 8 week course of radiotherapy can be safely compressed into 4 weeks with the same effectiveness as a longer course, by using very high-precision radiotherapy techniques to direct the radiation to the tumour and away from the healthy tissues. So far 700 patients of a total 1204 have been entered. If a shorter course is proved to be equivalent to a longer course, then using it will increase overall treatment capacity and possibly access to care, and reduce the emotional, financial and social impact of treatment on men with prostate cancer.
Programme
Operating Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
201865
Name
Levine Mark N
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Randomized Controlled Trials 2
Projecttitle
A randomized trial of a shorter radiation fraction schedule for the treatment of localised prostate cancer
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$300,236
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Biochemical Clinical Failure; Dose Escalation; Hypofractionation; Prostate Cancer; Radiotherapy; Randomized Trial
Abstract
Prostate cancer is the most common cancer affecting Canadian men, and radiotherapy given from the outside (external beam) is frequently chosen by patients as an alternative to surgery to eradicate the tumour and cure the disease. Recent improvements in radiation treatment allow more radiation dose to be safely given than before, but this has extended the duration of a treatment course from a traditional 6-7 weeks to up to 8-9 weeks. Extending radiation treatment courses has improved cancer control, but is more inconvenient to patients and has placed a substantial economic burden on the health care system. Canadians often live remotely from radiation treatment centres, and prostate cancer patients have also been burdened with additional financial, emotional and social costs from the added weeks of treatment. This randomized trial is being conducted in centres across Canada and in Australia to determine whether an 8 week course of radiotherapy can be safely compressed into 4 weeks with the same effectiveness as a longer course, by using very high-precision radiotherapy techniques to direct the radiation to the tumour and away from the healthy tissues. So far 700 patients of a total 1204 have been entered. If a shorter course is proved to be equivalent to a longer course, then using it will increase overall treatment capacity and possibly access to care, and reduce the emotional, financial and social impact of treatment on men with prostate cancer.
Competitiondate
201003
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Levine, Mark N; Catton, Charles N; Lukka, Himanshu R
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $300,236~ $0~